FIELD: chemistry.
SUBSTANCE: described are novel alkyl cyclohexyl esters of 5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulene derivatives of formula I where R is C1-8-alkyl, optionally substituted with a halogen, hydroxy or C1-12-alkoxy, CF3, C3-7-cycloalkyl, a 4-6-member heterocycloalkyl containing one O, R is H, C1-8-alkyl, optionally substituted with OH, -(CH2)q-Ra, where Ra is a 6-member heteroaryl containing one N, -C(O)-C1-8-alkyl, where the alkyl is optionally substituted with OH, -C(O)(CH2)qOC(O)-C1-8-alkyl, -C(O)O-C1-8-alkyl, -S(O)2-C1-8-alkyl or -S(O)2NRiRii, where Ri and Rii are identical and denote C1-8-alkyl, q=1, R3 is Cl or F, and a pharmaceutical composition containing said compounds.
EFFECT: compounds are V1a receptor antagonists and can be used in medicine.
15 cl, 69 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
ARYLCYCLOHEXYL ESTERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | 2009 |
|
RU2507205C2 |
ARYL-CYCLOHEXYL-TETRAAZABENZO[e]AZULENES | 2011 |
|
RU2566759C2 |
ARYL-/HETEROARYL - CYCLOHEXENYL -TETRAAZABENZO[e]AZULENES AS VASOPRESSIN ANTAGONISTS | 2011 |
|
RU2568642C2 |
SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRA-AZA-BENZO[E]AZULENES | 2009 |
|
RU2514429C2 |
VASOPRESSIN V RECEPTOR ANTAGONISTS | 2005 |
|
RU2370497C2 |
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
ANELLATED CABAMOYLAZAHETEROCYCLES, FOCUSED LIBRARY, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2005 |
|
RU2281947C1 |
BENZAMIDE DERIVATIVES AS OXYTOCIN AGONISTS AND VASOPRESSIN ANTAGONISTS | 2004 |
|
RU2340617C2 |
BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
DERIVATIVES OF BENZODIAZEPINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2278865C2 |
Authors
Dates
2014-03-27—Published
2009-11-09—Filed